Marcy L. Verduin, M.D.
Dr. Verduin is not currently accepting new patients.
Dr. Verduin is the Associate Dean for Students and a Professor of Psychiatry at the University of Central Florida College of Medicine. She is board-certified in Adult Psychiatry with added qualifications in Addictions and has extensive experience with undergraduate and graduate medical education, research and clinical practice.
Dr. Verduin received her bachelor’s degree in chemistry from the New College of Florida and her M.D. degree from the University of Florida College of Medicine. She then completed a psychiatric residency at the Medical University of South Carolina, where she later became a chief resident. She also completed her post-doctoral fellowship at the Medical University of South Carolina, which was funded by the National Institute on Drug Abuse, as well as an addiction psychiatry fellowship.
In 2007, Dr. Verduin became the first psychiatry faculty member at UCF’s new medical school, where she played an integral role in the development of the curriculum across the four-year educational program. In 2010, she moved into the role of Associate Dean for Students, overseeing the areas of Admissions, Student Academic Support, Student Financial Services, Student Records, Student Services, and Student Wellness. She serves as a member of the Board of Regents for the American College of Psychiatrists, the Book Editor for the Journal of Psychiatric Practice, and as an ad hoc reviewer for psychiatric, education, and addictions journals.
Dr. Verduin has served as the principal investigator or a co-investigator on several clinical and human laboratory trials, including a Career Development (K23) Award through the National Institute on Drug Abuse. Her clinical work is based at UCF Health, where she provides consultative services on an outpatient basis. She recently concluded her term as AAP President, and has since been elected the Vice Chair of the AAMC Southern Group on Student Affairs.
- McRae AL, Verduin ML, Tolliver BK, Carter RE, Herrin AE, Brady KT, Anderson SJ. An open-label trial of aripiprazole treatment in dual diagnosis individuals: safety and efficacy. J Dual Diagn, in press.
- Tolliver BK, McRae AL, Verduin ML, Anderson SJ, Brady KT. Reversible elevation of triglycerides in dual diagnosis patients taking aripiprazole: a case series. J Clin Psychopharmacol 2008;28(4):464-7.
- Gao K, Verduin ML, Kemp DE, Tolliver B, Ganocy SJ, Elhaj O, Brady K, Findling RL, Calabrese JR. Clinical Correlates of Patients with Rapid Cycling Bipolar Disorder and a Recent History of Substance Use Disorder: a Subtype Comparison. J Clin Psychiatry 2008;69(7):1057-63.
- Brady KT, Verduin ML, Tolliver BK. Treatment of patients comorbid for addiction and other psychiatric disorders. Curr Psychiatry Rep 2007;9(5):374-80.
- Verduin ML, Upadhyaya H. Beating nicotine: medication algorithm helps teens quit. Current Psychiatry 2007;6(10):65-74.
- Verduin ML. Ask the expert: treatment strategy for co-occurring bipolar disorder and alcohol abuse. FOCUS 2007;V(2):170-1.
- Verduin ML, Payne RA, McRae AL, Back SE, Simpson SA, Sarang RY, Brady KT. Assessment of club drug use in a treatment-seeking sample of individuals with marijuana dependence. Am J Addict 2007;16:1-4.
- Verduin ML, McKay S, Brady KT. Gabapentin in comorbid anxiety and substance use. Am J Addict 2007;16:1-2.
- Brady KT, Tolliver BK, Verduin ML. Alcohol use and anxiety: diagnostic and management issues. Am J Psychiatry 2007;164:217-21.
- Brady KT, Verduin ML. Pharmacotherapy of co-morbid mood, anxiety, and substance use disorders. Subst Use Misuse 2005; 40:2021-41.
- Verduin ML, Carter RE, Brady KT, Myrick H, Timmerman M. Health service use among persons with comorbid bipolar and substance use disorders. Psychiatr Serv 2005; 56(4):475-80.